Original Research
Blood and cardiovascular health parameters after supplementing with ketone salts for six weeks
Submitted: 26 November 2018 | Published: 24 April 2019
About the author(s)
Angelia M. Holland, Department of Kinesiology, Augusta University, Augusta, United StatesAhmed S. Qazi, Department of Kinesiology, Augusta University, Augusta, United States
Kristen N. Beasley, Department of Kinesiology, Augusta University, Augusta, United States
Hannah R. Bennett, Department of Kinesiology, Augusta University, Augusta, United States
Abstract
Background: Exogenous ketone salts (KS) have been administered as treatment for various health conditions; however, the safety of chronic supplementation in a healthy population has yet to be explored.
Aim: This study examined the safety of KS supplementation for 6 weeks in healthy, young adults and determined the effects of KS on blood ketone levels.
Setting: Data collection occurred in a laboratory at Augusta University.
Methods: Twenty-three men and women (aged 18–35 years old) supplemented with KS or a placebo (PLA) twice per day for 6 weeks in a randomised, double-blinded, PLA-controlled design. Baseline and post-intervention measures included body mass index (BMI), resting blood pressure and heart rate, questionnaires assessing mood and energy, urinalysis, and venous blood measures, including comprehensive metabolic panel (CMP), lipid panel, and complete blood count (CBC). In addition, the participants consumed the assigned supplement during the baseline and post-intervention visits; blood ketone levels were assessed immediately before and after 30 and 60 min post-supplementation.
Results: Systolic blood pressure was significantly lower (p < 0.05) after supplementing with KS for 6 weeks but not PLA. All other health parameters remained unchanged by KS supplementation, including BMI, resting heart rate, urinalysis, CMP, lipid panel, and CBC. After acute administration of KS but not PLA, blood ketone levels were significantly elevated (p < 0.001) 30 and 60 min after supplementation at both baseline and post-intervention visits.
Conclusion: Chronic KS supplementation seems safe, significantly elevates blood ketone levels 30 and 60 min after supplementation and may lower blood pressure. Future explorations should determine the success of KS supplementation as a strategy to combat hypertension.
Keywords
Metrics
Total abstract views: 16580Total article views: 17058
Crossref Citations
1. SPORCU PERFORMANSINI ARTIRAN GÜNCEL BESİN TAKVİYELERİ
Hakan Bor
Ankara Üniversitesi Beden Eğitimi ve Spor Yüksekokulu SPORMETRE Beden Eğitimi ve Spor Bilimleri Dergisi vol: 23 issue: 1 first page: 189 year: 2025
doi: 10.33689/spormetre.1535816
2. Potential Therapeutic Effects of Exogenous Ketone Supplementation for Type 2 Diabetes: A Review
Jeremy J. Walsh, Étienne Myette-Côté, Helena Neudorf, Jonathan P. Little
Current Pharmaceutical Design vol: 26 issue: 9 first page: 958 year: 2020
doi: 10.2174/1381612826666200203120540
3. Exogenous ketone supplementation: an emerging tool for physiologists with potential as a metabolic therapy
Kaja Falkenhain, Hashim Islam, Jonathan P. Little
Experimental Physiology vol: 108 issue: 2 first page: 177 year: 2023
doi: 10.1113/EP090430
4. Effect of Acute and Chronic Ingestion of Exogenous Ketone Supplements on Blood Pressure: A Systematic Review and Meta-Analysis
Alexis Marcotte-Chénard, Renaud Tremblay, Kaja Falkenhain, Jonathan P. Little, Eléonor Riesco
Journal of Dietary Supplements vol: 21 issue: 3 first page: 408 year: 2024
doi: 10.1080/19390211.2023.2289961
5. Metabolism of Exogenous D-Beta-Hydroxybutyrate, an Energy Substrate Avidly Consumed by the Heart and Kidney
Bernard Cuenoud, Mickaël Hartweg, Jean-Philippe Godin, Etienne Croteau, Mathieu Maltais, Christian-Alexandre Castellano, André C. Carpentier, Stephen C. Cunnane
Frontiers in Nutrition vol: 7 year: 2020
doi: 10.3389/fnut.2020.00013
6. 14-Day Ketone Supplementation Lowers Glucose and Improves Vascular Function in Obesity: A Randomized Crossover Trial
Jeremy J Walsh, Helena Neudorf, Jonathan P Little
The Journal of Clinical Endocrinology & Metabolism vol: 106 issue: 4 first page: 1738 year: 2021
doi: 10.1210/clinem/dgaa925
